Advertisement

Topics

Genovis AB GENO Financial and Strategic SWOT Analysis Review [Updated: 13062017] Prices from USD $125

09:56 EDT 19 Jun 2017 | BioPortfolio Report Blog

Genovis AB GENO Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.

Highlights

Genovis AB Genovis develops, produces and markets enzyme products, which facilitate the development and quality control of biological drugs. The company's products are used for antibody molecules analysis to identify and characterize proteins, antibody based biotherapeutics; monoclonal antibodies, antibody drug conjugates and biosimilars. Its SmartEnzymes product portfolio encompasses FabRICATOR IdeS, GingisKHAN KGP, FabULOUS SpeB, GlycINATOR EndoS49, FabRICATOR Z IdeZ, GingisREX Rgp and IgGZERO EndoS. Genovis also offers antibody fragmentation services for different species and subclasses of Immunoglobulin G antibodies. The company offers its products to medical device, pharmaceutical and biotechnology sectors as well as contract manufacturing companies. It has presence in Massachusetts, the US; Europe and other countries. Genovis is headquartered in Lund, Sweden.

Genovis AB Key Recent Developments

May 30,2017: Genovis expands its product portfolio and launches three products for glycan analysis
May 02,2017: Genovis expands its product portfolio and launches FabALACTICA
Feb 27,2017: Genovis Announces YearEnd Report JanuaryDecember 2016
Aug 29,2016: Genovis: HalfYearly Report January June 2016
Jun 03,2016: Genovis launches FabULOUS Fab kit

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Genovis AB GENO Financial and Strategic SWOT Analysis Review [Updated: 13062017] Prices from USD $125

NEXT ARTICLE

More From BioPortfolio on "Genovis AB GENO Financial and Strategic SWOT Analysis Review [Updated: 13062017] Prices from USD $125"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Enzymes
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...